ARTICLE | Clinical News
Herceptin trastuzumab: Completed Phase III enrollment
August 1, 2011 7:00 AM UTC
Genentech Inc., South San Francisco, Calif. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Swit...